We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Adult Stem Cells Can Also Self-Renew

By Biotechdaily staff writers
Posted on 11 Jul 2005
In a ground-breaking study, scientists have discovered that adult, or post-natal, stem cells have the same ability as embryonic stem cells to multiply, which was not previously known.

Embryonic stem cells are often favored over adult or post-natal stem cells because it was generally believed that embryonic stem cells had a greater capacity to multiply than post-natal stem cells, making them more desirable to research as a potential treatment.

"Scientists have typically believed that adult or post-natal stem cells grow old and die much sooner than embryonic stem cells, but this study demonstrates that is not the case,” said senior author Dr. Johnny Huard, Ph.D., director of the Growth and Development Laboratory at Children's Hospital of Pittsburgh (PA, USA).

Researchers in Dr. Huard's laboratory were able to expand post-natal stem cells to a population level comparable to that reached by researchers using embryonic stem cells. Prior research showed that embryonic stem cells could undergo more than 200 population doublings before the cells begin to die. The researchers discovered that a unique population of muscle-derived stem cells was able to undergo more than 200 population doublings as well while keeping the ability to regenerate muscle in an animal model, a finding indicating that they could maintain their treatment potential. The study findings were reported in the July 1, 2005, issue of Molecular Biology of the Cell.

In addition to avoiding the current debate about the research use of embryonic stem cells, the use of post-natal cells could offer another important advantage: autoimmunity. With post-natal stem cells taken from the recipient and then reintroduced in an autologous manner, rejection would not be an issue.





Related Links:
Children's Hospital of Pittsburgh

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ESR Analyzer
miniiSED™

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
11 Jul 2005  |   BioResearch

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
11 Jul 2005  |   BioResearch

New Method Simplifies Preparation of Tumor Genomic DNA Libraries
11 Jul 2005  |   BioResearch